Dr Lal PathLabs Ltd. is a leading diagnostic laboratory and pathology services provider in India. It was established in 1949 by Dr S.K. Lal and is headquartered in New Delhi. The company operates a network of over 2000 collection centres and more than 200 laboratories and provides services in over 300 cities and towns across India.
The company offers a wide range of clinical laboratory tests and services, including biochemical tests, immunological tests, microbiology tests, haematology tests, histopathology tests, cytology tests and molecular diagnostics tests. It also provides a variety of preventive health checkup packages.
Dr Lal PathLabs Ltd. has a strong presence in the online space and offers services such as online booking and test results, online payment and home sample collection. The company is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
LalPathLab Stock History
The stock of Dr Lal PathLabs Ltd began trading on the NSE on April 21, 2017, and on the BSE on May 1, 2017. The stock has experienced a steady upward trend since then, with a peak of Rs. 2362.10 (as of December 22, 2022). Over the past year, the stock has gained approximately 163%.
In April 2022, the company reported a revenue of Rs. 2140 crores for the financial year 2021-2022. The company’s net profit during the same period was Rs. 350 crores.
The company’s strong financial performance and its leadership position in the diagnostic laboratory industry are likely to drive the stock price higher in the near future.
Dr Lal PathLabs Ltd in recent news
- Dr Lal PathLabs and Cipla saw a jump of 6% amid renewed COVID fear.
- Dr Lal PathLab dropped 5% as Delhi Government’s free medical test from the new year.
- Dr. Lal PathLabs get AA rating by CARE Ratings
- Dr Lal PathLabs has reported a decrease of 8% in its net profit for Q3, which now stands at Rs 54 crore.
How to buy Lal PathLabs Ltd shares in India?
You can buy shares of Dr Lal PathLabs Ltd on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). You can buy shares through a stockbroker or an online trading platform.
To buy shares of Dr Lal PathLabs Ltd through a stockbroker, you must open a Demat and trading account with the stockbroker. You will have to fill out an account opening form, provide KYC documents and submit the form with the required fees. Once you have opened the account, you can place an order to buy the shares of Dr Lal PathLabs Ltd.
You can also buy shares of Dr Lal PathLabs Ltd through an online trading platform. To buy shares through an online trading platform, you must first open a Demat and trading account with the platform. You will have to fill out an account opening form, provide KYC documents and submit the form with the required fees. Once you have opened the account, you can log in to the platform and place an order to buy the shares of Dr Lal PathLabs Ltd.
Some online platforms to buy Lal PathLabs Stock are Zerodha, Upstox, 5Paisa, HDFC Securities, Angel Broking, ICICI Direct, Kotak Securities, etc.
Lal PathLabs Ltd Share Price Prediction 2023-2030
For a better understanding, let us see the price targets and predictions for Lal PathLabs Limited’s share price over the years
Lal PathLabs Ltd Share Price Target 2023 is 3690.57 INR
| When | Maximum Price | Minimum Price |
| January 2023 | ₹2,106.84 | ₹1,937.39 |
| February 2023 | ₹1,990.78 | ₹1,815.98 |
| March 2023 | ₹1,863.08 | ₹1,586.99 |
| April 2023 | ₹1,969.39 | ₹1,745.69 |
| May 2023 | ₹1,891.16 | ₹1,454.74 |
| June 2023 | ₹2,269.39 | ₹1,745.69 |
| July 2023 | ₹2,723.27 | ₹2,094.82 |
| August 2023 | ₹2,995.60 | ₹2,304.30 |
| September 2023 | ₹3,145.38 | ₹2,419.52 |
| October 2023 | ₹2,995.60 | ₹2,304.30 |
| November 2023 | ₹3,295.16 | ₹2,534.74 |
| December 2023 | ₹3,690.57 | ₹2,838.90 |
Dr Lal PathLabs Ltd has been performing well in the last few years and is expected to continue its strong performance in the future. However, in the initial 3 months, price could be seen dropping, followed by a pump in April and then from June onwards, we could see price pumping ending the year at a positive note. We expect the Dr Lal Path labs share price to reach Rs. 3690 by December 2023.
Maximum and minimum share price target of Dr lal path labs for March 2023 is ₹1,863.08 and ₹1,586.99 respectively.
Lal PathLabs Ltd Share Price Target 2024 is 5166.396 INR
| When | Maximum Price | Minimum Price |
| January 2024 | ₹3,884.81 | ₹2,988.32 |
| February 2024 | ₹4,364.96 | ₹3,637.47 |
| March 2024 | ₹4,594.70 | ₹3,735.52 |
| April 2024 | ₹4,177.00 | ₹3,213.07 |
| May 2024 | ₹3,480.83 | ₹2,677.56 |
| June 2024 | ₹4,177.00 | ₹3,213.07 |
| July 2024 | ₹3,550.45 | ₹2,752.28 |
| August 2024 | ₹3,905.49 | ₹3,099.60 |
| September 2024 | ₹4,100.77 | ₹3,154.44 |
| October 2024 | ₹4,824.43 | ₹3,711.10 |
| November 2024 | ₹5,065.65 | ₹3,896.66 |
| December 2024 | ₹5,166.96 | ₹3,974.59 |
Analysts expect the stock price of Dr Lal PathLabs Ltd to reach Rs. 5166 by December 2024. The stock price is expected to reach this level due to the company’s strong financials and growth prospects. Investing in Dr Lal PathLabs Ltd shares could be a good option to generate returns.
Lal PathLabs Ltd Share Price Target 2025 is 6267.61 INR
| When | Maximum Price | Minimum Price |
| January 2025 | ₹5,270.30 | ₹4,054.08 |
| February 2025 | ₹5,547.69 | ₹4,267.45 |
| March 2025 | ₹5,825.07 | ₹4,480.83 |
| April 2025 | ₹5,200.96 | ₹4,000.74 |
| May 2025 | ₹4,728.14 | ₹3,637.03 |
| June 2025 | ₹5,200.96 | ₹4,000.74 |
| July 2025 | ₹4,953.29 | ₹3,810.23 |
| August 2025 | ₹5,159.68 | ₹3,968.98 |
| September 2025 | ₹5,417.66 | ₹4,167.43 |
| October 2025 | ₹5,742.72 | ₹4,417.48 |
| November 2025 | ₹6,144.72 | ₹4,726.70 |
| December 2025 | ₹6,267.61 | ₹4,821.24 |
Predictions are bullish on the share price of Dr Lal PathLabs Ltd for 2025. Maximum and minimum share price target for LalPathLabs in 2025 is ₹6,267.61 and ₹3,637.03 respectively. This shows more than 300% gain from its current price.
Lal PathLabs Limited Share Price Target 2026-2030
| Year | Maximum Price | Minimum Price |
| 2026 | ₹4,387.33 | ₹3,071.13 |
| 2027 | ₹3,729.23 | ₹2,610.46 |
| 2028 | ₹6,712.61 | ₹4,698.83 |
| 2029 | ₹13,788.74 | ₹9,652.12 |
| 2030 | ₹15,355.64 | ₹10,748.95 |
After ending the year 2025 at a high note of ₹6,267.61, the Dr Lal Path labs share price will fall to the mark of ₹ 4,387 in the next year. It will drop further to ₹3,729 in 2027 but soon in the next year, it will again see growth and will reach ₹6,712. If you are assuming this is a huge spike, well, that’s yet to come in this story. It will witness a big bull run and reach ₹13,788 in 2029 and will end the decade at a price of ₹15,355.
Lal PathLabs Ltd Financial Condition: Last 5 years
| Narration | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | |||
| Sales | 1,056.92 | 1,203.42 | 1,330.36 | 1,581.27 | 2,087.41 | |||
| Expenses | 792.83 | 909.76 | 986.79 | 1,144.82 | 1,526.09 | |||
| Operating Profit | 264.09 | 293.66 | 343.57 | 436.45 | 561.32 | |||
| Other Income | 31.13 | 45.95 | 55.05 | 51.16 | 51.95 | |||
| Depreciation | 33.06 | 38.22 | 72.81 | 77.20 | 108.11 | |||
| Interest | 0.84 | 0.84 | 15.31 | 16.00 | 30.18 | |||
| Profit before tax | 261.32 | 300.55 | 310.50 | 394.41 | 474.98 | |||
| Tax | 89.57 | 100.08 | 82.91 | 97.93 | 124.69 | |||
| Net profit | 170.73 | 199.18 | 225.94 | 291.62 | 344.83 | |||
| EPS | 20.50 | 23.91 | 27.12 | 35.01 | 41.40 | |||
| Price to earning | 42.76 | 43.67 | 51.68 | 77.33 | 63.07 | |||
| Price | 876.30 | 1,044.30 | 1,401.70 | 2,707.05 | 2,610.70 | |||
| RATIOS: | ||||||||
| Dividend Payout | 21.96% | 25.10% | 44.27% | 57.16% | 29.01% | |||
| OPM | 24.99% | 24.40% | 25.83% | 27.60% | 26.89% |
FAQs
Will Lal PathLabs Ltd Stock price grow in 2023?
Yes, it is expected that the stock price of Dr Lal PathLabs Ltd will grow in 2023. Analysts are bullish on the stock and expect the share price to reach Rs. 3,690 by December 2023. The stock price is expected to reach this level due to the company’s strong financials, growth prospects, and leadership position in the diagnostic laboratory industry. Investing in Dr Lal PathLabs Ltd shares could be a good option to generate returns.
What is the market cap of Dr Lal PathLabs Ltd?
As of January 29th, 2023, the market capitalisation of Dr Lal PathLabs Ltd. is Rs. 17.00T Crore. The company’s market capitalisation is the total value of its outstanding shares.
What future is anticipated for Dr Lal PathLabs Ltd in 2024?
Analysts anticipate the stock price of Dr Lal PathLabs Ltd to hit Rs. 1,500 by March 2024. The stock price is predicted to reach this level due to the company’s solid financials, growth prospects, and command position in the diagnostic laboratory industry. Investing in Dr Lal PathLabs Ltd shares could be a good way to make returns.
Can Dr Lal PathLabs Ltd reach 10,000 INR?
It is possible that the stock price of Dr Lal PathLabs Ltd could reach 10,000 INR in the year 2029 or 2030. However, it is impossible to predict exactly when this may happen as the stock price depends on several factors such as the company’s financial performance, market conditions, and investor sentiment. Investing in Dr Lal PathLabs Ltd shares could be a good option to generate returns.
What is Dr Lal Path Lab’s share price target for 2025?
Maximum and minimum share price target for Lal Path Labs for 2025 is ₹6,267.61 and ₹3,637.03 respectively
What is Lal Path Lab’s share price target for 2030?
Lal Path labs has a very high chance of growing in next 7 years. The share price could reach a maximum of ₹15,355.64 and a minimum of ₹10,748.95.
Conclusion
Dr Lal PathLabs Ltd is a leading diagnostic laboratory and pathology services provider in India. It has been performing well in the last few years and is expected to continue its strong performance in the future. Analysts expect the stock price of Dr Lal PathLabs Ltd to reach Rs. 4,500 by March 2024. The company’s strong financial performance and its leadership position in the diagnostic laboratory industry are likely to drive the stock price higher in the near future. Investing in Dr Lal PathLabs Ltd shares could be a good option to generate returns.
In the past few quarters, the Lal Path Lab share price have been correcting. After the tremendous rise during the Covid times, the share price needed correction. However, after correcting by 50%, I think Lal Path Labs is close to its true value. One can start accumulating Lal Path Labs for a long term hold.
In latest earnings report (Q3FY22), Dr Lal PathLabs has posted a of 8% decrease in its net profit, which now stands at Rs 54 crore.
However, this article on ‘Dr Lal Path Lab Share Price Target 2023 to 2030’ is for educational purpose only and not an investment advise. Please consult a SEBI registered financial advisor before investing in LalPathLabs.
Linkedin
